Ophthalmology therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Persistent Corneal Epithelial Defects (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... The report provides comprehensive information on the therapeutics under development for Persistent Corneal Epithelial Defects, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and M......" | 30-Apr-2021 | $2000 | |
Myopia (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... a, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and d......" | 30-Apr-2021 | $2000 | |
Wet (Neovascular / Exudative) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... ation pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Wet (Neovascular / Exudative) Macular Degeneration, complete with analysis by Stage of Development, Drug Target, Mechanism ......" | 30-Apr-2021 | $2500 | |
Global Ophthalmic Drugs Market Research Report 2021, Forecast to 2026By Multimarket Insight "...... rt forecast global Ophthalmic Drugs market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values ......" | 30-Apr-2021 | $2680 | |
Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... rehensive information on the therapeutics under development for Allergic Rhino-Conjunctivitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also co......" | 30-Apr-2021 | $2000 | |
Anterior Uveitis (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... cs under development for Anterior Uveitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the t......" | 30-Apr-2021 | $2000 | |
Choroidal Neovascularization (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... ensive information on the therapeutics under development for Choroidal Neovascularization, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers......" | 30-Apr-2021 | $2000 | |
Macular Degeneration (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... e therapeutics under development for Macular Degeneration, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological......" | 30-Apr-2021 | $2000 | |
Dry (Atrophic) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... port provides comprehensive information on the therapeutics under development for Dry (Atrophic) Macular Degeneration, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule ......" | 30-Apr-2021 | $2000 | |
Geographic Atrophy (Ophthalmology) - Drugs in Development, 2021By Global Markets Direct "...... apeutics under development for Geographic Atrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action ......" | 30-Apr-2021 | $2000 | |
|